Influence of IPV on GOR in Infants From 0 to 12 Months.
Influence of Intrapulmonary Percussive Ventilation (IPV) on Gastro-oesophageal Reflux (GOR) in Infants From 0 to 12 Months.
1 other identifier
interventional
67
1 country
1
Brief Summary
The purpose of this study is to determine whether Intrapulmonary Percussive Ventilation ( airway clearance technique) provokes or aggravates gastro-oesophageal reflux in infants from 0 to 12 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 24, 2014
CompletedFirst Posted
Study publicly available on registry
April 28, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2015
CompletedResults Posted
Study results publicly available
March 17, 2015
CompletedFebruary 10, 2017
December 1, 2016
1.3 years
April 24, 2014
February 23, 2015
December 22, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Refluxes
Every two hours after feeding, the number of refluxes during 20 minutes are measured. The mean number of refluxes during these periods were calculated and compared to the number of refluxes during 20 minutes of IPV
during 20 minutes of IPV compared to mean number of refluxes during 20 minutes.
Study Arms (1)
Intrapulmonary Percussive Ventilation
EXPERIMENTALnumber of refluxes during 20 min of IPV ( rate : 300/min, p = 10cmH2O) at least 120 min after feeding
Interventions
20 min IPV freq 300/min, p 10cmH2O
Eligibility Criteria
You may qualify if:
- infants from 0 to 12 months
- impedance monitoring
You may not qualify if:
- gestational age \< 24w
- anti-reflux medication
- Nissen fundoplication
- no parental consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UZ Brussel
Jette, Brussels Capital, 1090, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- filip van ginderdeuren
- Organization
- vrije universiteit brussel
Study Officials
- PRINCIPAL INVESTIGATOR
fili van ginderdeuren
Vrije Universiteit Brussel
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PT, Drs
Study Record Dates
First Submitted
April 24, 2014
First Posted
April 28, 2014
Study Start
September 1, 2013
Primary Completion
January 1, 2015
Study Completion
January 1, 2015
Last Updated
February 10, 2017
Results First Posted
March 17, 2015
Record last verified: 2016-12